The novel Cln1R151X mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The novel Cln1R151X mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy
Authors
Keywords
-
Journal
HUMAN MOLECULAR GENETICS
Volume 24, Issue 1, Pages 185-196
Publisher
Oxford University Press (OUP)
Online
2014-09-10
DOI
10.1093/hmg/ddu428
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of Palmitoyl Protein Thioesterase 1 in Human THP1 Monocytes and Macrophages and Characterization of Unique Biochemical Activities for This Enzyme
- (2013) Ran Wang et al. BIOCHEMISTRY
- The role of nonsense-mediated decay in neuronal ceroid lipofuscinosis
- (2013) Jake N. Miller et al. HUMAN MOLECULAR GENETICS
- A Novel c.776_777insA Mutation in CLN1 Leads to Infantile Neuronal Ceroid Lipofuscinosis
- (2013) Jake N. Miller et al. JOURNAL OF CHILD NEUROLOGY
- Long-term nonsense suppression therapy moderates MPS I-H disease progression
- (2013) Gwen Gunn et al. MOLECULAR GENETICS AND METABOLISM
- Location- and sex-specific differences in weight and motor coordination in two commonly used mouse strains
- (2013) Attila D. Kovács et al. Scientific Reports
- Advances in the treatment of neuronal ceroid lipofuscinosis
- (2013) Dolan Sondhi et al. Expert Opinion on Orphan Drugs
- Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy
- (2012) Refik Kayali et al. HUMAN MOLECULAR GENETICS
- New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses
- (2012) R. E. Williams et al. NEUROLOGY
- Pharmaceutical therapies to recode nonsense mutations in inherited diseases
- (2012) Hui-Ling Rose Lee et al. PHARMACOLOGY & THERAPEUTICS
- Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses
- (2011) Maria Kousi et al. HUMAN MUTATION
- Juvenile neuronal ceroid lipofuscinosis: clinical course and genetic studies in Spanish patients
- (2011) María-Socorro Pérez-Poyato et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Stop codon read-through with PTC124 induces palmitoyl-protein thioesterase-1 activity, reduces thioester load and suppresses apoptosis in cultured cells from INCL patients
- (2011) Chinmoy Sarkar et al. MOLECULAR GENETICS AND METABOLISM
- N-acetylcysteine prevents loss of dopaminergic neurons in theEAAC1−/−mouse
- (2010) Ari E. Berman et al. ANNALS OF NEUROLOGY
- Read-Through Strategies for Suppression of Nonsense Mutations in Duchenne/ Becker Muscular Dystrophy: Aminoglycosides and Ataluren (PTC124)
- (2010) Richard S. Finkel JOURNAL OF CHILD NEUROLOGY
- Structural basis of neuronal ceroid lipofuscinosis 1
- (2009) Kazuki Ohno et al. BRAIN & DEVELOPMENT
- Involvement of NMDAR2A tyrosine phosphorylation in depression-related behaviour
- (2009) Sachiko Taniguchi et al. EMBO JOURNAL
- Cerebellar pathology and motor deficits in the palmitoyl protein thioesterase 1-deficient mouse
- (2009) Shannon L. Macauley et al. EXPERIMENTAL NEUROLOGY
- Variant Late Infantile Neuronal Ceroid Lipofuscinosis Because of CLN1 Mutations
- (2009) Alessandro Simonati et al. PEDIATRIC NEUROLOGY
- Neuronal ceroid lipofuscinoses
- (2008) Anu Jalanko et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started